| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1992PNAS...89.1616P |
| P356 | DOI | 10.1073/PNAS.89.5.1616 |
| P932 | PMC publication ID | 48503 |
| P698 | PubMed publication ID | 1542652 |
| P5875 | ResearchGate publication ID | 21612378 |
| P2093 | author name string | Fusco A | |
| Santoro M | |||
| Bongarzone I | |||
| Grieco M | |||
| Pierotti MA | |||
| Jenkins RB | |||
| Herrmann MA | |||
| Sozzi G | |||
| Miozzo M | |||
| Monzini N | |||
| P2860 | cites work | Developmentally regulated expression of a human "finger"-containing gene encoded by the 5' half of the ret transforming gene | Q24298289 |
| Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing | Q24339506 | ||
| cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line | Q28117244 | ||
| A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences | Q28282360 | ||
| Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death | Q29620000 | ||
| Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS. | Q34234846 | ||
| PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas | Q34372878 | ||
| Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation | Q34559025 | ||
| Differential expression of the normal and of the translocated human c-myc oncogenes in B cells | Q37344941 | ||
| Suppressors of the malignant phenotype | Q37833593 | ||
| A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases | Q42807477 | ||
| Molecular cloning of a new transforming gene from a chemically transformed human cell line. | Q45345810 | ||
| Megabase inversions in the human genome as physiological events | Q48254994 | ||
| The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). | Q52246921 | ||
| Fused transcript of abl and bcr genes in chronic myelogenous leukaemia | Q59064021 | ||
| Oncogenicity of the ret transforming gene in MMTV/ret transgenic mice | Q67656982 | ||
| Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma | Q68920794 | ||
| High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma | Q69398273 | ||
| Human ret proto-oncogene mapped to chromosome 10q11.2. | Q69558463 | ||
| Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC | Q70111753 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1616-1620 | |
| P577 | publication date | 1992-03-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. | |
| P478 | volume | 89 |
| Q35746558 | 'Chromosomal Rainbows' Detect Oncogenic Rearrangements of Signaling Molecules in Thyroid Tumors |
| Q36949780 | 20 years of RET/PTC in thyroid cancer: clinico-pathological correlations |
| Q62397584 | A PDGFRB-positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene |
| Q34013654 | A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells |
| Q37686882 | A novel read-through transcript JMJD7-PLA2G4B regulates head and neck squamous cell carcinoma cell proliferation and survival |
| Q42800418 | A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma |
| Q40849447 | Accumulation of allelic losses on chromosome 10 in human gliomas at recurrence |
| Q72684603 | Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident |
| Q33813441 | Advances in cancer cytogenetics |
| Q45829274 | Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC. |
| Q47833329 | Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population |
| Q34550400 | BAC-FISH assays delineate complex chromosomal rearrangements in a case of post-Chernobyl childhood thyroid cancer |
| Q33950311 | Balanced translocation (3;7)(p25;q34): another mechanism of tumorigenesis in follicular thyroid carcinoma? |
| Q39700806 | CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1. |
| Q47634740 | CCDC6: the identity of a protein known to be partner in fusion. |
| Q42497065 | Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma |
| Q34085418 | Case-Control Genome-Wide Association Study of Attention-Deficit/Hyperactivity Disorder |
| Q34711521 | Chromosomal rearrangements in post-Chernobyl papillary thyroid carcinomas: evaluation by spectral karyotyping and automated interphase FISH |
| Q34214053 | Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma |
| Q52512616 | Chromosomal translocations in human cancer. |
| Q37800593 | Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia |
| Q58813561 | Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas |
| Q72046520 | Cytogenetic findings in 31 papillary thyroid carcinomas |
| Q37212268 | DNA probe pooling for rapid delineation of chromosomal breakpoints |
| Q42281387 | Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation |
| Q35833808 | Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing |
| Q40819992 | Diagnostic and prognostic markers in differentiated thyroid cancer |
| Q34721796 | Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues |
| Q34359802 | Discovery of structural alterations in solid tumor oligodendroglioma by single molecule analysis |
| Q43572298 | Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome |
| Q57382361 | FLT4 Receptor Tyrosine Kinase Gene Mapping to Chromosome Band 5q35 in Relation to the t(2;5), t(5;6), and t(3;5) Translocations |
| Q43599672 | Gene rearrangements in radiation-induced thyroid carcinogenesis |
| Q34288667 | H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization. |
| Q43752781 | High prevalence of RET tyrosine kinase activation in Mexican patients with papillary thyroid carcinomas |
| Q34194261 | How familial cancer genes and environmentally induced oncogenes have changed the endocrine landscape |
| Q34474368 | Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity |
| Q33691784 | Influence of RET/PTC1 and RET/PTC3 oncoproteins in radiation-induced papillary thyroid carcinomas on amounts of cytoskeletal protein species |
| Q35977327 | Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma |
| Q34617571 | Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage. |
| Q35976585 | Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours |
| Q67482944 | Keeping track of the translocations |
| Q34550445 | Kinase expression and chromosomal rearrangements in papillary thyroid cancer tissues: investigations at the molecular and microscopic levels |
| Q42828135 | Loss of function effect of RET mutations causing Hirschsprung disease. |
| Q54781483 | Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis. |
| Q34662980 | Low VHL mRNA expression is associated with more aggressive tumor features of papillary thyroid carcinoma. |
| Q24611227 | Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A |
| Q38466453 | Molecular cytogenetic characterization of chromosome 9-derived material in a human thyroid cancer cell line |
| Q37924088 | Molecular genetics and diagnosis of thyroid cancer |
| Q35208510 | Molecular pathogenesis of thyroid cancer |
| Q42798821 | New breakpoints in both the H4 and RET genes create a variant of PTC-1 in a post-Chernobyl papillary thyroid carcinoma |
| Q36361115 | New treatment in advanced thyroid cancer |
| Q40698212 | Oncogenes and anti-oncogenes in human epithelial thyroid tumors |
| Q27824825 | Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer |
| Q36135918 | RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material |
| Q74235643 | RET rearrangements in familial papillary thyroid carcinomas |
| Q54250039 | RET/PTC activation in human thyroid carcinomas |
| Q33599429 | RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlation |
| Q28214459 | RET/PTC rearrangement in thyroid tumors |
| Q70588382 | Regional assignment of the gene coding for a human Graves' disease autoantigen to 10q21.3-q22.1. |
| Q41019851 | Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. |
| Q41878891 | Rethinking the role of oncogenes in papillary thyroid cancer initiation |
| Q24533621 | Shc and Enigma are both required for mitogenic signaling by Ret/ptc2. |
| Q28776010 | Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B |
| Q55023816 | Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: different spectrum of mutations in sporadic type from hereditary type. |
| Q45130742 | TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. |
| Q79894991 | TPM3/PDGFRB fusion transcript and its reciprocal in chronic eosinophilic leukemia |
| Q24311495 | The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain |
| Q34735847 | The Pathology of Medullary Carcinoma of the Thyroid: Review of the Literature and Personal Experience on 62 Cases |
| Q41350370 | The RET proto-oncogene: a challenge to our understanding of disease pathogenesis |
| Q38496502 | The emerging complexity of gene fusions in cancer |
| Q36760027 | The impact of translocations and gene fusions on cancer causation |
| Q58453418 | The management of thyroid nodules and cancer in the molecular era |
| Q47920723 | The molecular genetics of endocrine tumours |
| Q38004366 | The pituitary tumor transforming gene in thyroid cancer |
| Q36455074 | The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid |
| Q40931125 | The role of the immune system in anti-tumour responses. Potential for drug therapy |
| Q34293074 | The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2. |
| Q38135137 | Translational research in endocrine surgery |
| Q37363960 | Translocations in epithelial cancers |
| Q38020834 | Vandetanib for the treatment of metastatic medullary thyroid cancer |
| Q46211426 | XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway. |
Search more.